Alzheimer’s disease progression by geographical region in a clinical trial setting

Alzheimer’s disease progression by geographical region in a clinical trial setting

Bibliographic Details
Main Authors:	Henley, David B, Dowsett, Sherie A, Chen, Yun-Fei, Liu-Seifert, Hong, Grill, Joshua D, Doody, Rachelle S, Aisen, Paul, Raman, Rema, Miller, David S, Hake, Ann M, Cummings, Jeffrey
Format:	Online
Language:	English
Published:	BioMed Central 2015
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4481070/

Similar Items

Comparing recruitment, retention, and safety reporting among geographic regions in multinational Alzheimer’s disease clinical trials
by: Grill, Joshua D, et al.
Published: (2015)

The Alzheimer's Disease Cooperative Study Prevention Instrument Project: Longitudinal Outcome of Behavioral Measures as Predictors of Cognitive Decline
by: Banks, Sarah Jane, et al.
Published: (2014)

Peripheral and central effects of γ-secretase inhibition by semagacestat in Alzheimer’s disease
by: Doody, Rachelle S, et al.
Published: (2015)

Drug development in Alzheimer’s disease: the path to 2025
by: Cummings, Jeffrey, et al.
Published: (2016)

Cognitive Impairment Precedes and Predicts Functional Impairment in Mild Alzheimer’s Disease
by: Liu-Seifert, Hong, et al.
Published: (2015)

Progress in understanding variability in cognitive responses to cholinesterase inhibitor treatment
by: Pavlik, Valory N, et al.
Published: (2011)

On the path to 2025: understanding the Alzheimer’s disease continuum
by: Paul S. Aisen, et al.
Published: (2017-08-01)

Modeling the course of Alzheimer's disease to improve clinical trials: symposium report
by: Spiegel, René, et al.
Published: (2013)

Evaluating the cognitive effects of donepezil 23 mg/d in moderate and severe Alzheimer’s disease: analysis of effects of baseline features on treatment response
by: Sabbagh, Marwan, et al.
Published: (2013)

Q & A: The Alzheimer's disease neuroimaging initiative
by: Aisen, Paul S
Published: (2011)

Advances in Alzheimer’s Disease Drug Development
by: Rafii, Michael S, et al.
Published: (2015)

A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease
by: Turner, R. Scott, et al.
Published: (2015)

Validity, Significance, Strengths, Limitations, and Evidentiary Value of Real-World Clinical Data for Combination Therapy in Alzheimer's Disease: Comparison of Efficacy and Effectiveness Studies
by: Atri, Alireza, et al.
Published: (2012)

Effects of donepezil 23 mg on Severe Impairment Battery domains in patients with moderate to severe Alzheimer's disease: evaluating the impact of baseline severity
by: Ferris, Steven, et al.
Published: (2013)

Factors that influence survival in a probable Alzheimer disease cohort
by: Rountree, Susan D, et al.
Published: (2012)

Lipoprotein-associated phospholipase A2, homocysteine, and Alzheimer's disease
by: Doody, Rachelle S., et al.
Published: (2015)

Representativeness of European clinical trial populations in mild Alzheimer’s disease dementia: a comparison of 18-month outcomes with real-world data from the GERAS observational study
by: Catherine Reed, et al.
Published: (2018-04-01)

Should persons with autosomal dominant AD be included in clinical trials? Authors' response
by: Szigeti, Kinga, et al.
Published: (2011)

Should EOAD patients be included in clinical trials?
by: Szigeti, Kinga, et al.
Published: (2011)

Cognitively-Related Basic Activities of Daily Living Impairment Greatly Increases the Risk of Death in Alzheimers Disease
by: Liang, Fu-Wen, et al.
Published: (2016)

Duloxetine and Pregnancy Outcomes: Safety Surveillance Findings
by: Hoog, Sharon L, et al.
Published: (2013)

Clinical translation of progress in molecular endocrinology
by: Dowsett, M
Published: (2000)

Effect of diabetes on caregiver burden in an observational study of individuals with Alzheimer’s disease
by: Lebrec, Jeremie, et al.
Published: (2016)

Metabolome in progression to Alzheimer's disease
by: Orešič, M, et al.
Published: (2011)

Amyloid-related imaging abnormalities from trials of solanezumab for Alzheimer's disease
by: Carlson, Christopher, et al.
Published: (2016)

Diversity of Blastocystis subtypes in dogs in different geographical settings
by: Wang, Wenqi, et al.
Published: (2013)

Association of Anti-VEGF Injections with Progression of Geographic Atrophy
by: Ryan Enslow, et al.
Published: (2016-01-01)

Association of Anti-VEGF Injections with Progression of Geographic Atrophy
by: Enslow, Ryan, et al.
Published: (2016)

Alzheimer's pathology in primary progressive aphasia
by: Rohrer, Jonathan D., et al.
Published: (2012)

Blood Platelets in the Progression of Alzheimer’s Disease
by: Gowert, Nina S., et al.
Published: (2014)

Progress in diagnosis and management of Alzheimer's disease
by: Antony, Bayer
Published: (2012)

Alzheimer's disease diagnostic criteria: practical applications
by: Cummings, Jeffrey
Published: (2012)

Getting to NO Alzheimer's Disease: Neuroprotection versus Neurotoxicity Mediated by Nitric Oxide
by: Balez, Rachelle, et al.
Published: (2016)

Autosomal-dominant Alzheimer's disease: a review and proposal for the prevention of Alzheimer's disease
by: Bateman, Randall J, et al.
Published: (2011)

Psychosis in Alzheimer's Disease in the National Alzheimer's Disease Coordinating Center Uniform Data Set: Clinical Correlates and Association with Apolipoprotein E
by: DeMichele-Sweet, Mary Ann A., et al.
Published: (2011)

Can theory of mind deficits be measured reliably in people with mild and moderate Alzheimer’s dementia?
by: Choong, Caroline S.M., et al.
Published: (2013)

Can theory of mind deficits be measured reliably in people with mild and moderate Alzheimer’s dementia?
by: Choong, Caroline SM, et al.
Published: (2013)

Fluid Biomarkers in Clinical Trials of Alzheimer’s Disease Therapeutics
by: Ritter, Aaron, et al.
Published: (2015)

A Systematic Review of Biomarkers for Disease Progression in Alzheimer's Disease
by: McGhee, David J. M., et al.
Published: (2014)

Effect of TTP488 in patients with mild to moderate Alzheimer’s disease
by: Burstein, Aaron H, et al.
Published: (2014)